Cargando…

The effects of two types of renin-angiotensin system inhibitors on the hypertension induced by new pressor protein associated with beta-factor XIIa in rats

BACKGROUND AND PURPOSE: New pressor protein (NPP) is a human plasma enzyme, which is structurally related to the beta-fragment of activated factor XII. The present study aimed to compare the effects of angiotensin converting enzyme inhibitors (captopril) and angiotensin type 1 receptor blocker (losa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pejhan, Akbar, Gohari, Ali, Rakhshani, Mohammad Hassan, Papageorgiou, Peter C., Mustafa, Muhammad Ibrar, Golmohammadi, Rahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306251/ https://www.ncbi.nlm.nih.gov/pubmed/32582357 http://dx.doi.org/10.4103/1735-5362.283817

Ejemplares similares

ON THE NATURE OF THE PRESSOR ACTION OF RENIN
por: Page, Irvine H.
Publicado: (1939)

Supercomputer Search for the New Inhibitors of the Coagulation Factor XIIa
por: Sulimov, A. V., et al.
Publicado: (2022)

THE CARDIAC FACTOR IN THE "PRESSOR" EFFECTS OF RENIN AND ANGIOTONIN
por: Hill, W. H. Philip, et al.
Publicado: (1941)

RENIN PROTEINURIA IN THE RAT : I. THE RELATION BETWEEN THE PROTEINURIA AND THE PRESSOR EFFECT OF RENIN
por: Addis, T., et al.
Publicado: (1949)

A KINETIC ANALYSIS OF THE RENIN-ANGIOTONIN PRESSOR SYSTEM AND THE STANDARDIZATION OF THE ENZYMES RENIN AND ANGIOTONASE
por: Plentl, Albert A., et al.
Publicado: (1943)

A CRYSTALLINE PRESSOR SUBSTANCE (ANGIOTONIN) RESULTING FROM THE REACTION BETWEEN RENIN AND RENIN-ACTIVATOR
por: Page, Irvine H., et al.
Publicado: (1940)

GENETIC INFLUENCE ON THE RENIN-ANGIOTENSIN SYSTEM : EVIDENCE FOR A RENIN INHIBITOR IN HYPERTENSION-PRONE RATS
por: Iwai, Junichi, et al.
Publicado: (1970)

New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation
por: Tashchilova, Anna, et al.
Publicado: (2022)

Microscale Parallel Synthesis of Acylated Aminotriazoles Enabling the Development of Factor XIIa and Thrombin Inhibitors
por: Platte, Simon, et al.
Publicado: (2021)

Impact of renin-angiotensin system inhibitors and beta-blockers on dental implant stability
por: Saravi, Babak, et al.
Publicado: (2021)

THE REACTION OF PERIPHERAL BLOOD VESSELS TO ANGIOTONIN, RENIN, AND OTHER PRESSOR AGENTS
por: Abell, Richard G., et al.
Publicado: (1942)

Renin-Angiotensin System - Considerations for Hypertension and Kidney
por: Yim, Hyung Eun, et al.
Publicado: (2008)

New Infestin-4 Mutants with Increased Selectivity against Factor XIIa
por: Kolyadko, Vladimir N., et al.
Publicado: (2015)

Effect of renin-angiotensin system blocker on COVID-19 in young patients with hypertension
por: Kuzeytemiz, Mustafa, et al.
Publicado: (2022)

Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat
por: Wangensteen, Rosemary, et al.
Publicado: (2022)

Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors
por: Drobni, Zsofia D., et al.
Publicado: (2022)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Urotensin II Exerts Pressor Effects By Stimulating Renin And Aldosterone Synthase Gene Expression
por: Caroccia, Brasilina, et al.
Publicado: (2017)

Role of the central renin-angiotensin system in hypertension (Review)
por: Su, Chuanxin, et al.
Publicado: (2021)

Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
por: Meng, Juan, et al.
Publicado: (2020)

ROLE OF EXTRAPULMONARY CONVERSION IN MEDIATING THE SYSTEMIC PRESSOR ACTIVITY OF ANGIOTENSIN I
por: Oates, Helen F., et al.
Publicado: (1974)

Brain Oscillations Elicited by the Cold Pressor Test: A Putative Index of Untreated Essential Hypertension
por: Papageorgiou, Christos, et al.
Publicado: (2017)

Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization
por: Sim, Hui Wen, et al.
Publicado: (2020)

Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension
por: Zeng, Weiwei, et al.
Publicado: (2022)

Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation
por: Aoki, Taro, et al.
Publicado: (2020)

Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
por: Golpe, Rafael, et al.
Publicado: (2020)

Mortality and Pre‐Hospitalization use of Renin‐Angiotensin System Inhibitors in Hypertensive COVID‐19 Patients
por: Chen, Chen, et al.
Publicado: (2020)

Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension
por: Xu, Wei, et al.
Publicado: (2022)

Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
por: Golpe, Rafael, et al.
Publicado: (2020)

High-Throughput Docking and Molecular Dynamics Simulations towards the Identification of Potential Inhibitors against Human Coagulation Factor XIIa
por: Xu, Dongfang, et al.
Publicado: (2020)

Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension
por: Moon, Ju-Young
Publicado: (2013)

Translational studies on augmentation of intratubular renin–angiotensin system in hypertension
por: Navar, L Gabriel
Publicado: (2013)

Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension
por: Shim, Kwang Yong, et al.
Publicado: (2018)

Vaccine Development against the Renin-Angiotensin System for the Treatment of Hypertension
por: Azegami, Tatsuhiko, et al.
Publicado: (2019)

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020)

COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
por: Zores, Florian, et al.
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19
por: Sackin, Henry
Publicado: (2021)

Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
por: Tsampasian, Vasiliki, et al.
Publicado: (2022)

Safety and Efficacy of Renin–Angiotensin–Aldosterone System Inhibitors in COVID-19 Population
por: Sattar, Yasar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4dtkhjkt2f9rgsktbi4vgrpq8t